Skip to content
AnalystLens

CACI International Annual Report, Year Ended Jun 30, 2021

Filing Date
Filed August 17, 2021
Period End
June 30, 2021
Security
CACI
In the record · 2016–202610-K1110-Q338-K122

CACI filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 122 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Feb ’16Feb ’16
  2. Material agreement8-K · Dec ’19Dec ’19
  3. Leadership change8-K · Oct ’22Oct ’22
  4. Leadership change8-K · Jun ’26Jun ’26

Summary

Summary of the 10-K filed August 17, 2021. Cited figures are marked; the original filing is the authoritative source.

CACI International Inc (CACI), a Delaware holding company with operations in the U.S. and Europe, reported fiscal 2021 (year ended June 30, 2021) revenue of $6.04 billiona, up 5.7 percent from $5.72 billion in fiscal 2020, with 5.0 percent of that growth coming from organic revenue.

Net income rose 42.3 percent to $457.4 millionb, and diluted earnings per share were $18.30, compared with $12.61 a year earlier. Income from operations increased 17.9 percent to $539.5 million. The company stated that 95.5 percent of its revenue came from federal government contracts, with 69.3 percent from the Department of Defense.

Total backlog reached $24.2 billionc, up 12.0 percent, although contract awards of $9.2 billion were down 20.7 percent. Cash flow and balance sheet activity were shaped by capital deployment. Operating cash flow was $592.2 million, up 14.2 percent.

The company paid $356.3 milliond for business acquisitions, most notably Ascent Vision Technologies, and repurchased $509.1 million of common stock, including a $500.0 million accelerated share repurchase agreement entered March 12, 2021. Total long-term debt principal rose to $1.74 billion, with $945.0 million drawn on the $1.5 billion revolving facility and $797.6 million outstanding on the term loan. Goodwill totaled $3.63 billion, or a substantial share of $6.17 billion in total assets.

Management concluded that internal control over financial reporting was effective as of June 30, 2021. Key risks in the filing center on dependence on federal government funding, the possibility of contract termination or non-renewal, competitive rebidding, and budget uncertainty, including continuing resolutions.

Legal exposure includes the Al Shimari and Abbass lawsuits related to Iraqi detainee claims, which the company describes as completely without merit and is vigorously defending. The company has never paid a cash dividend and states it intends to retain earnings for operations and expansion.

Key Highlights

  1. Revenue of $6.04 billion, up 5.7 percent year over year, with 5.0 percent organic growth; Department of Defense revenue increased $186.0 million and Federal Civilian revenue increased $117.9 million.
  2. Net income of $457.4 million, up 42.3 percent, and diluted EPS of $18.30 versus $12.61; the effective tax rate fell to 8.4 percent, aided by a $56.2 million benefit from CARES Act NOL carryback.
  3. Total backlog of $24.2 billion, up 12.0 percent, though FY2021 contract awards of $9.2 billion declined 20.7 percent; remaining performance obligations were $6.9 billion.
  4. Operating cash flow of $592.2 million, up 14.2 percent, with capital expenditures of $73.1 million.
  5. Capital deployment included $356.3 million in acquisitions (Ascent Vision Technologies) and $509.1 million in share repurchases, including a $500.0 million accelerated share repurchase.
  6. Customer concentration is high: 95.5 percent of revenue came from U.S. government agencies, and the top ten contracts accounted for 33.8 percent of revenue.
  7. Total debt principal of $1.74 billion under a $2.44 billion Credit Facility, with interest rate swaps covering $800.0 million; the Credit Facility matures June 30, 2024.

Financial Statements

FY2021 against FY2020

Line itemFY2021FY2020Change
Revenue$6.04B$5.72B+5.7%
SG&A Expenses$1.45B$1.43B+1.1%
Operating Expenses$5.50B$5.26B+4.6%
Operating Income$539.45M$457.70M+17.9%
Interest Expense$39.84M$56.06M−28.9%
Net Income$457.44M$321.48M+42.3%
EPS (Basic)$18.52$12.84+44.2%
EPS (Diluted)$18.30$12.61+45.1%
Shares Outstanding (Basic)24.70M25.03M−1.3%
Shares Outstanding (Diluted)24.99M25.48M−1.9%

Frequently Asked Questions

  1. How did CACI's revenue and profitability trend in fiscal 2021?

    Revenue grew 5.7 percent to $6.04 billion, with 5.0 percent from organic growth and the rest from acquisitions. Income from operations rose 17.9 percent to $539.5 million, and net income increased 42.3 percent to $457.4 million. Part of the net income increase reflected a lower effective tax rate of 8.4 percent, which benefited from a $56.2 million NOL carryback benefit under the CARES Act.

  2. How dependent is CACI on the U.S. government?

    Federal government contracts accounted for 95.5 percent of total revenue in FY2021, and Department of Defense contracts accounted for 69.3 percent. The filing notes that government contracts can be terminated for convenience or not renewed, and that the company has a relatively small share of its addressable market, which the company estimates at approximately $230 billion.

  3. What is the company's backlog and how has new business trended?

    Total backlog was $24.2 billion at June 30, 2021, up 12.0 percent from $21.6 billion a year earlier. However, contract awards in FY2021 were $9.2 billion, a decrease of 20.7 percent, and funded backlog was $3.3 billion. The filing also notes that backlog may not translate fully into revenue because of unfunded amounts and government deobligations.

  4. How is CACI using its cash and what is its debt position?

    Operating cash flow was $592.2 million. The company spent $356.3 million on acquisitions and $509.1 million on share repurchases, financed partly by net borrowings of $329.1 million under its Credit Facility. Total long-term debt principal was $1.74 billion at June 30, 2021, and the company stated it has never paid a cash dividend and intends to retain earnings.

  5. What legal proceedings could affect CACI?

    The filing describes the Al Shimari and Abbass lawsuits, brought by Iraqi plaintiffs alleging mistreatment at Abu Ghraib prison and in U.S. custody in Iraq. The Supreme Court denied CACI's petition for certiorari in Al Shimari on June 28, 2021, and CACI filed a motion to dismiss on July 23, 2021. The company states it is vigorously defending the cases and believes they are completely without merit.